Janney Montgomery Scott’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,207
Closed -$220K 3178
2026
Q1
$220K Sell
4,207
-92
-2% -$4.68K ﹤0.01% 2579
2025
Q4
$220K Buy
+4,299
New +$199K ﹤0.01% 2759
2019
Q2
Sell
-7,103
Closed -$257K 2096
2019
Q1
$257K Buy
+7,103
New +$237K ﹤0.01% 1737
2018
Q4
Sell
-10,953
Closed -$431K 2040
2018
Q3
$431K Hold
10,953
﹤0.01% 1516
2018
Q2
$408K Sell
10,953
-100
-0.9% -$3.63K ﹤0.01% 1502
2018
Q1
$378K Hold
11,053
﹤0.01% 1479
2017
Q4
$362K Hold
11,053
﹤0.01% 1488
2017
Q3
$345K Buy
11,053
+100
+0.9% +$2.93K ﹤0.01% 1437
2017
Q2
$305K Hold
10,953
﹤0.01% 1434
2017
Q1
$282K Sell
10,953
-700
-6% -$17.4K ﹤0.01% 1435
2016
Q4
$267K Sell
11,653
-1,250
-10% -$29.9K ﹤0.01% 1403
2016
Q3
$337K Buy
+12,903
New +$322K 0.01% 1135
2016
Q1
Sell
-11,444
Closed -$363K 1396
2015
Q4
$363K Buy
11,444
+1,590
+16% +$48.7K 0.01% 959
2015
Q3
$275K Buy
9,854
+1,944
+25% +$67.9K 0.01% 1097
2015
Q2
$281K Buy
+7,910
New +$258K 0.01% 1537

Other funds holding SBIO

Janney Montgomery Scott's SBIO Position: Q2 2026 in Review

Janney Montgomery Scott sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 4,207 shares — an estimated $220K sold.

Janney Montgomery Scott first reported a position in SBIO in Q2 2015 and held it in 15 quarters. The position peaked at $431K in Q3 2018. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Janney Montgomery Scott reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
  • Janney Montgomery Scott sold 4,207 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $220K.
  • Janney Montgomery Scott first reported a position in ALPS Medical Breakthroughs ETF in Q2 2015 and held it in 15 quarters.
  • Janney Montgomery Scott's ALPS Medical Breakthroughs ETF position peaked at $431K in Q3 2018.
  • 66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.